Item Type | Name |
Concept
|
Antigen-Presenting Cells
|
Concept
|
Antigens
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
Concept
|
Histocompatibility Antigens Class II
|
Concept
|
Antigens, Neoplasm
|
Concept
|
Antigens, Surface
|
Concept
|
HLA-D Antigens
|
Concept
|
HLA-DQ Antigens
|
Concept
|
HLA-DR Antigens
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Antigens, CD
|
Concept
|
CD4 Antigens
|
Concept
|
HLA-DR2 Antigen
|
Concept
|
Lymphocyte Function-Associated Antigen-1
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Antigen Presentation
|
Concept
|
CD28 Antigens
|
Concept
|
B7-1 Antigen
|
Concept
|
B7-2 Antigen
|
Academic Article
|
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
|
Academic Article
|
Dendritic cells signal T cells in the absence of exogenous antigen.
|
Academic Article
|
Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
|
Academic Article
|
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
|
Academic Article
|
Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands.
|
Academic Article
|
T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
|
Academic Article
|
CD4+CD28- costimulation-independent T cells in multiple sclerosis.
|
Academic Article
|
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
|
Academic Article
|
The initiation of the autoimmune response in multiple sclerosis.
|
Academic Article
|
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
|
Academic Article
|
T cell LFA-1 engagement induces HuR-dependent cytokine mRNA stabilization through a Vav-1, Rac1/2, p38MAPK and MKK3 signaling cascade.
|
Academic Article
|
Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response.
|
Academic Article
|
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.
|
Academic Article
|
Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease.
|
Academic Article
|
Functional HLA-DM on the surface of B cells and immature dendritic cells.
|
Academic Article
|
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
|
Academic Article
|
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
|
Academic Article
|
Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
|
Academic Article
|
Pathogenic features of CD4+CD28- T cells in immune disorders.
|
Academic Article
|
Immunopathogenesis of the multiple sclerosis lesion.
|
Concept
|
CD52 Antigen
|